Filippo Peter Caldini [document 0]

Interim Chief Executive Officer at Establishment Labs Holdings Inc

Since March 1, 2025

Age

60 years

Education

Holds a BA in Political Science from Boston University, an MBA from Northeastern University, and a Master’s in International Economics and Management from Bocconi University.

Tenure

Joined as President on 08-20-2024 before being promoted to Interim Chief Executive Officer on 03-01-2025.

Also at Establishment Labs Holdings Inc

RSD[0

Rajbir S. Denhoy [document 0]

Chief Financial Officer

SRM[0

S. Ross Mansbach [document 0]

General Counsel and Chief Compliance Officer

About

Filippo "Peter" Caldini is a seasoned executive currently serving as the Interim Chief Executive Officer at ESTA, with a solid foundation in both education and industry experience.

He earned his BA in Political Science from Boston University, his MBA from Northeastern University, and a Master’s in International Economics and Management from Bocconi University, underscoring his strong academic background.

Prior to his role at ESTA, he held key leadership positions, including CEO roles at Acreage Holdings, Inc. and Bespoke Capital Acquisition Corp, as well as several executive positions at Pfizer Consumer Healthcare and Bayer AG, which provided him with significant industry expertise.

He joined ESTA as President on August 20, 2024, and was promoted to Interim Chief Executive Officer on March 1, 2025, tasked with steering the organization through strategic transitions and innovation.

$ESTA Performance Under Filippo Peter Caldini [document 0]

Past Roles

Organization	Role	Date Range	Details
Establishment Labs Holdings Inc. (ESTA)	President	Aug 2024 - Feb 2025	Preceded his appointment as Interim CEO
Acreage Holdings, Inc.	Chief Executive Officer	Dec 2020 - Jun 2023	N/A
Bespoke Capital Acquisition Corp.	Chief Executive Officer and Director	Jun 2019 - Dec 2020	N/A
Pfizer Consumer Healthcare	Regional President North America	2017 - 2019	N/A
Pfizer Consumer Healthcare	Regional President EMEA	2016 - 2017	N/A
Pfizer Consumer Healthcare	Leader, Northern European Cluster	2015 - 2016	N/A
Bayer AG	Head of Emerging Markets EMEA, General Manager of Bayer Consumer Care China, Head of the Nutritionals Strategic Business Unit	2009 - 2014	N/A
Wyeth Consumer Healthcare	Various Commercial Roles	2002 - 2009	Held roles of increasing responsibility in the commercial area

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Salary	$151,994	Annual (earned in 2024)	Base salary for 2024
Stock Awards	$399,977	Vests in 4 equal annual installments	Restricted stock unit awards
Option Awards	$598,672	Vests in 4 equal annual installments	Stock option awards
All Other Compensation	$16,449	As incurred during 2024	Breakdown: Life Insurance Premiums $654; Health Insurance Premiums $13,634; Other $2,161

Performance Compensation

Data from FY 2024

Performance Compensation

Attribute	Value	Additional Details
Target Bonus Opportunity ($USD)	$78,850	Pro-rated based on start date in August 2024
Bonus Earned ($USD)	$60,408	Based on performance metrics for 2024
Overall Performance Metrics	Corporate: 80%; Individual: 20%	Corporate factor achieved at 65% for 2024
Corporate Performance Breakdown	Revenue Targets: 35%; OPEX Targets: 25%; Year-End Cash Balance: 25%; Other Strategic Objectives: 15%	Metrics weighted accordingly
Threshold	None	No minimum requirement set
Maximum	None	No cap on bonus
Grant Date	August 20, 2024	Applicable for the cash-based incentive plan
Vesting Schedule	N/A	Not applicable as plan is cash-based
Evaluation Period	2024	Performance measured over the 2024 period